Applications including "Pharmacopeia"

GA113 - Residual solvents in pharmaceuticals -

GC InertSearch InertCap Pure-WAX
LB876 - Analysis of Cefoxitin -

LC InertSearch InertSustain C18
LB875 - Analysis of Levofloxacin -

LC InertSearch Inertsil ODS-3
LB874 - Analysis of Captopril and Captopril Disulfide -

LC InertSearch InertSustain AQ-C18
LB873 - Tacrolimus Extended-Release Capsules -

LC InertSearch InertSustain AQ-C18
LB872 - Analysis of Febuxostat -

LC InertSearch InertSustain Phenyl
LB871 - Analysis of Febuxostat -

LC InertSearch InertSustain Phenyl
LB870 - Analysis of Febuxostat -

LC InertSearch InertSustain Phenyl
LB867 - Analysis of Febuxostat -

LC InertSearch InertSustain C18
LB740 - Analysis of Acetaminophen -

LC InertSearch Inertsil ODS-3
LB739 - Analysis of Acetaminophen -

LC InertSearch Inertsil ODS-3
LB699 - Analysis of Refined Glucose (Japanese Pharmacopoeia 18th Edition, Glucose, Assay) -

LC InertSearch InertSphere Sugar-2
LB671 - Analysis of Sucrose (Under the condition of the PDG (Pharmacopeial Discussion Group) Stage 2 Drafts) -

LC InertSearch InertSphere Sugar-2
LB670 - Analysis of Sucrose (Under the condition of the PDG (Pharmacopeial Discussion Group) Stage 2 Drafts) -

LC InertSearch InertSphere Sugar-2
LT159 - Assay Test for Esomeprazole Magnesium Delayed -Release Capsules under USP Method -

LC Technical Note InertSustain C18
LT099 - Analysis of Valsartan -

LC Technical Note InertSustain C18
LT098 - Analysis of Amlodipine -

LC Technical Note Inertsil ODS-4 HP
LT097 - Analysis of Pioglitazone Hydrocloride -

LC Technical Note Inertsil ODS-4 HP
LB084 - Analysis of Olmesartan medoxomil (Under the Condition of United States Pharmacopeia 35-NF30) -

LC InertSearch InertSustain C18
GT101 - Analysis of memantine hydrochloride in accordance with the USP -

GC Technical Note
GA291 - Memantine Hydrochloride(Under the Condition of United States Pharmacopeia 39, Organic Impurities) -

GC InertSearch InertCap 5
GA290 - Memantine Hydrochloride(Under the Condition of United States Pharmacopeia 39, Assay) -

GC InertSearch InertCap 5
GA273 - Analysis of Saccharin(Under the Condition of the PDG (Pharmacopeial Discussion Group) Stage 6 Drafts) -

GC InertSearch InertCap 17
GA167 - Purity test of Benzyl alcohol by Japanese pharmacopoeia -

GC InertSearch InertCap WAX
GA166 - Purity test of Epirubicin Hydrochloride by Japanese pharmacopoeia -

GC InertSearch InertCap Pure-WAX
GA165 - Purity test of Magnesium stearate by Japanese pharmacopoeia -

GC InertSearch InertCap WAX
GA164 - Purity test of Magnesium stearate by Japanese pharmacopoeia -

GC InertSearch InertCap Pure-WAX
GA155 - Purity test of Colchicine by Japanese pharmacopoeia -

GC InertSearch InertCap Pure-WAX
GA154 - Purity test of Wood Creosote by Japanese pharmacopoeia -

GC InertSearch InertCap 1
GA145 - Purity test of Colchicine -

GC InertSearch InertCap WAX
GA134 - Higher Alcohols -

GC InertSearch InertCap 5
GA128 - Residual solvents in pharmaceuticals -

GC InertSearch InertCap 5
GA127 - Residual solvents in pharmaceuticals Class3 -

GC InertSearch InertCap 5
GA126 - Residual solvents in pharmaceuticals Class2 -

GC InertSearch InertCap 5
GA125 - Residual solvents in pharmaceuticals Class1 -

GC InertSearch InertCap 5
GA124 - Residual solvents in pharmaceuticals -

GC InertSearch InertCap 5
GA123 - Residual solvents in pharmaceuticals -

GC InertSearch InertCap 624

Applications including "Pharmacopeia"

GA113 - Residual solvents in pharmaceuticals -

LB876 - Analysis of Cefoxitin -

LB875 - Analysis of Levofloxacin -

LB874 - Analysis of Captopril and Captopril Disulfide -

LB873 - Tacrolimus Extended-Release Capsules -

LB872 - Analysis of Febuxostat -

LB871 - Analysis of Febuxostat -

LB870 - Analysis of Febuxostat -

LB867 - Analysis of Febuxostat -

LB740 - Analysis of Acetaminophen -

LB739 - Analysis of Acetaminophen -

LB699 - Analysis of Refined Glucose (Japanese Pharmacopoeia 18th Edition, Glucose, Assay) -

LB671 - Analysis of Sucrose (Under the condition of the PDG (Pharmacopeial Discussion Group) Stage 2 Drafts) -

LB670 - Analysis of Sucrose (Under the condition of the PDG (Pharmacopeial Discussion Group) Stage 2 Drafts) -

LT159 - Assay Test for Esomeprazole Magnesium Delayed -Release Capsules under USP Method -

LT099 - Analysis of Valsartan -

LT098 - Analysis of Amlodipine -

LT097 - Analysis of Pioglitazone Hydrocloride -

LB084 - Analysis of Olmesartan medoxomil (Under the Condition of United States Pharmacopeia 35-NF30) -

GT101 - Analysis of memantine hydrochloride in accordance with the USP -

GA291 - Memantine Hydrochloride(Under the Condition of United States Pharmacopeia 39, Organic Impurities) -

GA290 - Memantine Hydrochloride(Under the Condition of United States Pharmacopeia 39, Assay) -

GA273 - Analysis of Saccharin(Under the Condition of the PDG (Pharmacopeial Discussion Group) Stage 6 Drafts) -

GA167 - Purity test of Benzyl alcohol by Japanese pharmacopoeia -

GA166 - Purity test of Epirubicin Hydrochloride by Japanese pharmacopoeia -

GA165 - Purity test of Magnesium stearate by Japanese pharmacopoeia -

GA164 - Purity test of Magnesium stearate by Japanese pharmacopoeia -

GA155 - Purity test of Colchicine by Japanese pharmacopoeia -

GA154 - Purity test of Wood Creosote by Japanese pharmacopoeia -

GA145 - Purity test of Colchicine -

GA134 - Higher Alcohols -

GA128 - Residual solvents in pharmaceuticals -

GA127 - Residual solvents in pharmaceuticals Class3 -

GA126 - Residual solvents in pharmaceuticals Class2 -

GA125 - Residual solvents in pharmaceuticals Class1 -

GA124 - Residual solvents in pharmaceuticals -

GA123 - Residual solvents in pharmaceuticals -

Application Search